Compare WFCF & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WFCF | CGTX |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 158.8M |
| IPO Year | 2011 | 2021 |
| Metric | WFCF | CGTX |
|---|---|---|
| Price | $13.15 | $1.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 3.7K | ★ 938.3K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.82 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $25,512,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.26 | $0.22 |
| 52 Week High | $13.78 | $3.83 |
| Indicator | WFCF | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 60.00 | 51.98 |
| Support Level | $12.50 | $1.69 |
| Resistance Level | $13.15 | $1.77 |
| Average True Range (ATR) | 0.42 | 0.13 |
| MACD | 0.13 | 0.02 |
| Stochastic Oscillator | 100.00 | 74.44 |
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.